Autilio, C.
Echaide, M.
Cruz, A.
García-Mouton, C.
Hidalgo, A.
Da Silva, E.
De Luca, D.
Sørli, Jorid B.
Pérez-Gil, J.
Funding for this research was provided by:
Ministerio de Ciencia e Innovación (RTI2018-094564-B-I00)
Comunidad de Madrid (P2018/NMT-4389)
Article History
Received: 23 June 2020
Accepted: 27 November 2020
First Online: 12 January 2021
Change Date: 5 May 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41598-021-89532-6
Competing interests
: AA/Prof.De Luca has received research and educational grants from Chiesi Farmaceutici spa and ABBVIE inc and THERABRON inc.. He served as consultant and lecturer for Airway Therapeutics, Chiesi Pharmaceuticals spa and ABBVIE inc. Finally, he has been member of advisory boards for Chiesi Pharmaceuticals spa and ABBVIE inc. Prof. Perez-Gil has received research grants from Chiesi Farmaceutici spa and Airway Therapeutics. C.A., M.E., A.C., C. G.-M., A.H., E. D.S. and J.B.S. declare no competing interests.